Inhaled substance P, but not neurokinin A, enhances levels of alpha-2-macroglobulin in induced sputum of patients with mild asthma

E. L. J. van Rensen, M. C. Timmers, P. S. Hiemstra, T. A. Out, K. F. Rabe, P. J. Sterk (Leiden, Amsterdam, The Netherlands)

Source: Annual Congress 2001 - Noninvasive markers of airway inflammation, bronchoprovocation, or both?
Session: Noninvasive markers of airway inflammation, bronchoprovocation, or both?
Session type: Poster Discussion
Number: 1096
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. L. J. van Rensen, M. C. Timmers, P. S. Hiemstra, T. A. Out, K. F. Rabe, P. J. Sterk (Leiden, Amsterdam, The Netherlands). Inhaled substance P, but not neurokinin A, enhances levels of alpha-2-macroglobulin in induced sputum of patients with mild asthma. Eur Respir J 2001; 16: Suppl. 31, 1096

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The effects of inhaled steroids, leukotriene receptor antagonists and theophylline on induced sputum cell counts, serum and sputum ECP levels in mild persistent asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 261s
Year: 2001

Increased leukotriene and lower prostaglandin E2 concentrations in induced sputum of patients with eosinophilic asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 733s
Year: 2005

Decreased levels of myeloperoxidase in induced sputum of COPD patients after oral glucocorticoids treatment
Source: Eur Respir J 2002; 20: Suppl. 38, 404s
Year: 2002

One year monitoring of children with bronchial asthma and other allergic diseases treated with inhaled corticosteroids vs cromoglycates with serum ECP (S-ECP), FEV1, total IgE and blood eosinophil count - the influence of different therapy
Source: Eur Respir J 2002; 20: Suppl. 38, 432s
Year: 2002

Short term reductions in inhaled glucocorticoid doses in children with asthma may be associated with increased levels of serum eosinophil protein X
Source: Eur Respir J 2001; 18: Suppl. 33, 451s
Year: 2001

Effect of inhaled fluticasone on bronchial responsiveness to neurokinin A in asthma
Source: Eur Respir J 2002; 19: 997-1002
Year: 2002



Regular salbutamol use increases CXCL8 responses in asthma: relationship to the eosinophil response
Source: Eur Respir J 2003; 22: 118-126
Year: 2003



Cytokines concentrations in induced sputum of mild COPD patients. Correlation to clinical response to inhaled corticosteroids
Source: Eur Respir J 2002; 20: Suppl. 38, 309s
Year: 2002

Dose reduction of inhaled corticosteroids under concomitant medication with montelukast in patients with asthma
Source: Eur Respir J 2002; 20: 1080-1087
Year: 2002



Concentration of vasoactive intestinal peptide (VIP) and substance P (SP) in bronchi of patients with mild to moderate bronchial asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 583s
Year: 2005

Platelet activating factor receptor (PAFr) expression is increased in airways of COPD patients but is not attenuated by inhaled corticosteroid (ICS)
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013

Increased levels of hyaluronan in induced sputum from COPD patients
Source: Eur Respir J 2003; 22: Suppl. 45, 436s
Year: 2003

Sputum eosinophil counts in a large population of mild-to-moderate asthmatics: distribution, relationship with methacholine bronchial responsiveness and influence of a regular treatment with low doses of inhaled corticosteroids
Source: Eur Respir J 2001; 18: Suppl. 33, 531s
Year: 2001

Serum ECP levels do not correlate with degree of bronchial hyperresponsiveness in patients with cough variant asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 584s
Year: 2005

Serum level of soluble interleukin-2 receptors (sIL-2R) during acute asthma exacerbation, and its relation to severity and response to bronchodilator therapy
Source: Eur Respir J 2002; 20: Suppl. 38, 141s
Year: 2002

Do leukotriene antagonists reduce eosinophil numbers in induced sputum from asthmatic patients as a consequence of increased apoptosis induction?
Source: Eur Respir J 2002; 20: Suppl. 38, 584s
Year: 2002

The influence of antileukotriene therapy with montelukast (M) on thromboxane B2/leukotriene E4 (TXB2/LTE4) ratio in the urine of asthmatic subjects and other inflammatory markers
Source: Eur Respir J 2003; 22: Suppl. 45, 102s
Year: 2003

Increased serum levels of IL-8 and TNFα in severe asthma compared to mild asthma: relationship with airway calibre and exhaled nitric oxide (FeNO)
Source: Eur Respir J 2004; 24: Suppl. 48, 351s
Year: 2004

Elevated serum IgE, oral corticosteroid dependence and IL-17/22 expression in highly neutrophilic asthma
Source: Eur Respir J, 54 (5) 1900068; 10.1183/13993003.00068-2019
Year: 2019



Dual tachykinin NK1/NK2 antagonist DNK333 inhibits neurokinin A-induced bronchoconstriction in asthma patients
Source: Eur Respir J 2004; 23: 76-81
Year: 2004